GORE Flow Reversal System and GORE Embolic Filter Extension Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1397 participants.

Also called NCT01343667

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,397 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01343667
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01343667. Non-randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-11 (actual). Results posted on 2016-02-19.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
GORE Flow Reversal System and GORE Embolic Filter Extension Study
Acronym
FREEDOM
Condition
Carotid Stenosis
Condition
Constriction, Pathologic
Condition
Carotid Artery Diseases
Condition
Cerebrovascular Disorders
Condition
Brain Diseases
Condition
Central Nervous System Diseases
Condition
Nervous System Diseases
Condition
Arterial Occlusive Diseases
Condition
Vascular Diseases
Condition
Cardiovascular Diseases
Condition
Pathological Conditions, Anatomical
Intervention (Device)
Gore Flow Reversal System
Intervention (Device)
Gore Embolic Filter
Lead sponsor
W.L.Gore & Associates (class: industry)

Record details

Record id
cardio:ct-nct01343667
Content hash
ebc203f19b1fa741ce193a5498dddaef6ec7996faca15dbcadc37e20afabd10f